Hypertension in blacks: A literature review

Ethnicity and Disease

Volumn 13, Issue 4, 2003, Pages 456-462

  Ashaye, Modele O ^a   Giles, Wayne H ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Blacks; Epidemiology; Hypertension

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AWARENESS; BLOOD PRESSURE REGULATION; CAUSE OF DEATH; CULTURAL ANTHROPOLOGY; DATA ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE CONTROL; ETHNOLOGY; FEMALE; HEALTH CARE ORGANIZATION; HEALTH SURVEY; HEART DISEASE; HUMAN; HYPERTENSION; MALE; MASS SCREENING; MEDICAL LITERATURE; MEDICAL RESEARCH; NEGRO; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; STROKE; SYSTOLIC BLOOD PRESSURE; UNITED STATES;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AWARENESS; FEMALE; HUMANS; HYPERTENSION; MALE; MASS SCREENING; UNITED STATES;

EID: 0242659287     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Working Group on Primary Prevention of Hypertension. National High Blood Pressure Education Program Working Group Report on Primary Prevention of Hypertension. Arch Intern Med. 1993;153:186-208.
2. Benetos A, Thomas F, Bean K, Gautier S, Smulyan H, Guize L. Prognostic value of systolic and diastolic blood pressure in treated hypertensive men. Arch Intern Med. March 11, 2002;162(5):577-578.
3. Sesso HD, Stampfer MJ, Rosner B, et al. Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in men. Hypertension. November 2000;36(5):801-807.
4. He J, Whelton PK. Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease. J Hypertens. 1999; suppl 2:s7-s13.
5. Kannel WB. Risk stratification in hypertension: new insights from the Framingham study. Am J Hypertens. 2000;13;3s-10s.
6. Izzo JL Jr, Levy D, Black HR. Clinical Advisory Statement. Importance of systolic blood pressure in older Americans. Hypertension. May 2000;35(5):1019-1020.
7. Wolz M, Cutler J, Roccella EJ, et al. Statement from the National High Blood Pressure Education Program: prevalence of hypertension. Am J Hypertens. 2000;13(1, pt 1):103-104.
8. American Heart Association. 2003 Heart and Stroke Statistical Update. Dallas, Tex: American Heart Association.
9. US Census Bureau. Profile ofthe General Demographic Characteristics for the United States: 2000. Washington, DC: US Dept of Commerce, Statistics Administration; 2001.
10. Hoyert DL, Arias E, Smith BL, Murphy SL, Kochanek KD. Deaths: final data for 1999. Natl Vital Stat Rep. 2001;49:1-113.
11. Cherry DK, Woodwell DA. National Ambulatory Medical Care Survey: 2000 summary. Adv Data. 2002;328:1-32.
12. Department of Health and Human Services. Healthy People 2010. Vol 1. Atlanta, Ga: US Dept of Health and Human Services, Centers for Disease Control and Prevention; 2000.
13. Comstock GW. An epidemiologic study of blood pressure in a biracial community in southern United States. Am J Hyg. 1957;65: 271-315.
14. Pastor P, Makuc DM, Reuben C, Xia H. Charthook on trends in the health of Americans. Health, United States, 2002. Hyattsville, Md: National Center for Health Statistics; 2002.
15. Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157: 2413-2446.
16. Joint National Committee. The fifth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993;153:154-183.
17. National Kidney and Urologic Diseases Information Clearinghouse. Kidney and urologic disease statistics for the United States. Available at: http://www.usrds.org/2kpdf/A_incidence.pdf. Accessed September 10, 2001.
18. Clark LT. Primary prevention of cardiovascular disease in high-risk patients: physiologic and demographic risk factor differences between African-American and White American populations. Am J Med. 1999;107(2A):225-245.
19. Hall WD, Ferrario CM, Moore MA, et al. Hypertension-related morbidity and mortality in the southeastern United States. Am J Med Sci. April 1997;313(4):195-209.
20. Lackland DT, Egan BM. The dominant role of systolic hypertension as a vascular risk factor: evidence from the southeastern United States. Am J Med Sci. December 1999;318(6): 365-368.
21. Francis CK, Grant AO, Cooper RS, and the Working Group Members. Report of the Working Group on Research in Coronary Heart Disease in Blacks. Bethesda, Md: National Heart, Lung, and Blood Institute; March 1994.
22. He J, Klag MJ, Appel LJ, Charleston J, Whelton PK. Seven-year incidence of hypertension in a cohort of middle-aged African Americans and Whites. Hypertension. 1998;31:1130-1135.
23. James SA. Psychosocial and environmental factors in Black hypertension. In: Hall WD, Shulman NB, Saunders E, eds. Hypertension in Blacks: Epidemiology, Pathophysiology, and Treatment. Chicago, Ill: Year Book Medical Publishers, Inc; 1985:132-143.
24. Sowers JR, Ferdinand KC, Bakris GL, Douglas JG. Hypertension-related disease in African Americans. Factors underlying disparities in illness and its outcome. Postgrad Med. October 2002;112(4):24-26, 29-30, 33-34.
25. Hill MN, Bone LR, Kim MT, Miller DJ, et al. Barriers to hypertension care and control in young urban Black men. Am J Hypertens. October 1999;12(10, pt 1):951-958.
26. Smedley BD, Stith AY, Nelson AR, eds. Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Institute of Medicine of the National Academies; 2002.
27. Burt VL, Cutler JA, Higgins M, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population data from the health examination surveys, 1960 to 1991. Hypertension. 1995;26: 60-69.
28. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA. 2003;289: 2560-2571.
29. Perry HM Jr, Davis BR, Price TR, et al. Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 2000; 284:465-471.
30. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997;336: 1117-1124.
31. Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001;344(1)3-10.
32. Svetkey LP, Simons-Morton D, Vollmer VM, et al. Effects of dietary patterns on blood pressure: subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial. Arch Intern Med 1999; 159:285-293.
33. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. December 18, 2002; 288(23):2981-2997.
34. Douglas JG, Bakris GL, Epstein M, et al. Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med. March 10, 2003;163(5):525-541.
35. Moser M, Herbert PR. Prevention of disease progression, left ventricular hypertrophy, and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol. 1996;27: 1214-1218.
36. Ward HJ, Morisky DE, Lees NB, Fong R. A clinic and community-based approach to hypertension control for an undeserved minority population: design and methods. Am J Hypertens. 2000;13:2:177-183.
37. Hill MN, Bone LR, Kim MT, Miller DJ, Dennison CR, Levine DM. Barriers to hypertension care and control in young urban Black men. Am J Hypertens. 1999;12(4, pt 1): 951-958.
38. Management of patient compliance in the treatment of hypertension [abstract]. Report of the NHLBI Working Group. Hypertension. 1982;4:415-423.
39. Hypertension Detection and Follow up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow up Program; mortality by race, sex, and blood pressure level: a further analysis. Community Health. 1984;9:314-327.
40. The National Heart, Lung, and Blood Institute-The National High Blood Pressure Education Program. Available at: http://www.nhlbi.nih.gov/about/nhbpep/nhbp.pd.htm. Accessed September 10, 2001.
41. National Institutes of Health, The National Heart, Lung, and Blood Institute (NHLBI). Available at: http://www.nhlbi.nih.gov/resources/docs/plandisp.htm. Accessed September 10, 2001.
42. US Department of Health and Human Services. Annual Progress Reports of the CDC-funded Cardiovascular Health State Programs. Atlanta, Ga: US Dept of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion; 2001.
43. The International Society on Hypertension in Blacks. Available at: http://ishib.org/main/program_main.htm. Accessed September 12, 2001.
44. Whelton PK, He J, Appel LJ, et al, for the National High Blood Pressure Education Program Coordinating Committee. Primary prevention of hypertension. Clinical and public health advisory from the National High Blood Pressure Education Program. JAMA. 2002;288:1882-1888.